Abstract
To estimate prevalence of multidrug-resistant tuberculosis (MDR TB) in Harare, Zimbabwe, in 2012, we performed microbiologic testing on acid-fast bacilli smearpositive sputum samples from patients previously treated for TB. Twenty (24%) of 84 specimens were consistent with MDR TB. A national drug-resistance survey is needed to determine MDR TB prevalence in Zimbabwe.
Cite
CITATION STYLE
APA
Metcalfe, J. Z., Makumbirofa, S., Makamure, B., Sandy, C., Bara, W., Mungofa, S., … Mason, P. (2014). Drug-resistant tuberculosis in high-risk groups, Zimbabwe. Emerging Infectious Diseases, 20(1), 135–137. https://doi.org/10.3201/eid2001.130732
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free